Veterinary Medicines

PRIMUCELL FIP, Impfstoff gegen infektiöse Peritonitis bei Katzen

Authorised
  • Feline coronavirus, strain DF2-ts, Live
Download as PDF

Product identification

Medicine name:
PRIMUCELL FIP, Impfstoff gegen infektiöse Peritonitis bei Katzen
PRIMUCELL FIP, vaccin contre la péritonite infectieuse féline
PRIMUCELL FIP, vaccin tegen feline infectieuze peritonitis
Active substance:
  • Feline coronavirus, strain DF2-ts, Live
Target species:
  • Cat
Route of administration:
  • Nasal use

Product details

Active substance and strength:
  • Feline coronavirus, strain DF2-ts, Live
    63096.00
    cell culture infective dose 50
    /
    0.50
    millilitre(s)
Pharmaceutical form:
  • Nasal drops, lyophilisate and solvent for suspension
Withdrawal period by route of administration:
  • Nasal use
    • Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI06AD02
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Belgium
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Federal Agency For Medicines And Health Products
Authorisation number:
  • BE-V164001
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/03/2022
Download
French (PDF)
Published on: 9/03/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 9/03/2022
Download
French (PDF)
Published on: 9/03/2022
Download
German (PDF)
Published on: 9/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."